Benefits Of Taxol In Hormone Receptor Positive Breast Cancer

Featured Health Expert
3098_3020
EXPERT

Medical Oncologist's Response to Luteinizing Hormone-Releasing Hormone (LH-RH) Agonist Study

Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study on luteinizing hormone-releasing hormone (LH-RH) agonists, drugs that decrease the level of estrogen and other sex hormones in women.  LH-RH agonists for breast cancer treatment are used in Europe and Australia but rarely in the United States, which may explain why the study, published in a leading British medical journal got so little press in the States....
Read more

More information on "Benefits Of Taxol In Hormone Receptor Positive Breast Cancer"

From Our Experts

See more SharePosts »

From Our Sources

More on Breast Cancer »